Muscular abnormalities in liver cirrhosis

doi:10.3748/wjg.v27.i29.4862

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5782)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

458

WORD

128

HTML

3445

Figures (1-4)

269

Sum=4300

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

466

Download

1016

Sum=1482

Aug 7, 2021 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 7, 2021; 27(29): 4862-4878
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4862

Muscular abnormalities in liver cirrhosis

Andrej Hari

Andrej Hari, Department of Gastroenterology and Hepatology, General Hospital Celje, Celje 3000, Savinjska, Slovenia

Author contributions: Hari A contributed to acquisition and interpretation of data, drafting the article and final approval of the version of the article to be published.

Conflict-of-interest statement: The author declare that he has no conflict of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Andrej Hari, MD, Doctor, Department of gastroenterology and hepatology, General hospital Celje, Oblakova ulica 5, Celje 3000, Savinjska, Slovenia. andrej.hari@sb-celje.si

Received: March 7, 2021
Peer-review started: March 7, 2021
First decision: April 17, 2021
Revised: April 19, 2021
Accepted: July 19, 2021
Article in press: July 19, 2021
Published online: August 7, 2021
Processing time: 150 Days and 0.7 Hours

Core Tip

Core Tip: Knowledge regarding the influence of sarcopenia in the course of chronic liver disease has greatly expanded in the past ten years, especially with respect to cirrhosis. Data show that it has a great influence on disease decompensation and patient mortality, providing clues for the development of newer evaluation modalities and sarcopenia indices. Nonetheless, data regarding the therapeutic consequences and interventions remain scarce. This article attempts to summarize the current state of knowledge of this important clinical topic with a critical evaluation of some related groundbreaking studies.